AEON Biopharma, Inc.

AEON Biopharma, Inc. financial statements

AEON Biopharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 39.22M10-K
Cash and equivalentsUSD 3.01M10-Q
Total debtUSD 35.74MEODHD

AEON Biopharma, Inc. financials on 6ix · AEON Biopharma, Inc. on 6ix